ProCE Banner Activity

Slides: Expert Insight on Practice Changing Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Conference Coverage
Slideset

Download these slides from David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, with key data for gynecologic cancers presented at the 2023 SGO annual meeting, including practice changing results for novel agents in ovarian and endometrial cancers, and practical insights on recent approvals for cervical cancer.

Released: May 03, 2023

Share

Faculty

Linda R. Duska

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

David Scott Miller

David Scott Miller, MD, FACOG, FACS

Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Director and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics & Gynecology
Fred F. Florence Bioinformation Center
University of Texas Southwestern Medical Center
Medical Director of Gynecologic Oncology
Chair, Cancer Committee
Parkland Health & Hospital System
Dallas, Texas

Provided by

Provided by Clinical Care Options (CCO)

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Genmab, GlaxoSmithKline, Merck Sharp & Dohme Corp., Novocure Inc., and Seagen Inc.

AstraZeneca

Genmab

GlaxoSmithKline

Novocure, Inc

Seagen Inc.